Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
19 results
D3.278 - Cold urticaria: a case report
D3.279 - Biomarkers in anaphylaxis
D3.282 - Anaphylaxis to Gadoteric Acid: A Case Report
D3.283 - Taming the Unpredictable: Omalizumab’s Role in Idiopathic anaphylaxis and chronic spontaneous urticaria
D3.284 - Update of the Brazilian Anaphylaxis Registry
D3.285 - Improving Emergency Department Management of Adult Anaphylaxis: A Quality Improvement Initiative
D3.286 - Rapid Symptom Resolution in Oral Allergy Syndrome Following Anaphylm Administration: A Phase 2 Study Update
D3.287 - Adverse reactions and complications of Allergic Skin Test (SPT) in North Indian population
D3.288 - Asthma and Anaphylaxis Induced by Milk with NSAID as a Cofactor in Adult Patient Sensitized to Dairy Proteins Due to Environmental Exposure in a Dairy Farm
D3.289 - Pharmacokinetics of adrenaline administered via the ZiBiPen: First human trial findings
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy
D1.156 - Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients
D1.157 - Type II Cytokine-Mediated Regulation of Alarmin Receptors in B Cells: Implications for Eosinophilic Esophagitis
D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment
Download the app
The congress at your fingertips
Available on
Download